» Defymed and its partners granted for 5.5 million euros under the FP7 Health Program for the clinical validation of its bioartificial pancreas MAILPAN® Defymed - Innovative bioariticial medical devices for a better life

February 2014
M	T	W	T	F	S	S
« Oct
	1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28

February 2014

Defymed and its partners granted for 5.5 million euros under the FP7 Health Program for the clinical validation of its bioartificial pancreas MAILPAN®

Posted on January 31, 2013

Defymed together with CeeD, gathered a consortium made of seven prestigious partners from academia, clinical/public health research sector and industry/SMEs from three different European countries –Belgium, France and UK.

The project proposal intends to test the efficacy and safety of MAILPAN® in preclinical phases in large animals followed by clinical phases in human.

Complete english Press release- En

Complete french Press release- Fr